MetLife Investment Management’s ACM Research ACMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.98M Buy
31,382
+3,528
+13% +$249K 0.02% 769
2026
Q1
$1.1M Sell
27,854
-786
-3% -$41.7K 0.01% 1352
2025
Q4
$1.13M Sell
28,640
-2,037
-7% -$75.9K 0.01% 1358
2025
Q3
$1.2M Hold
30,677
– – 0.01% 1337
2025
Q2
$795K Hold
30,677
– – ﹤0.01% 1437
2025
Q1
$716K Sell
30,677
-368
-1% -$8.4K ﹤0.01% 1526
2024
Q4
$469K Buy
31,045
+2,123
+7% +$38.4K ﹤0.01% 1836
2024
Q3
$587K Hold
28,922
– – ﹤0.01% 1695
2024
Q2
$667K Buy
28,922
+3,862
+15% +$97.7K ﹤0.01% 1557
2024
Q1
$730K Hold
25,060
– – ﹤0.01% 1475
2023
Q4
$490K Hold
25,060
– – ﹤0.01% 1692
2023
Q3
$454K Hold
25,060
– – ﹤0.01% 1694
2023
Q2
$328K Hold
25,060
– – ﹤0.01% 1962
2023
Q1
$293K Hold
25,060
– – ﹤0.01% 1974
2022
Q4
$193K Hold
25,060
– – ﹤0.01% 2264
2022
Q3
$312K Hold
25,060
– – ﹤0.01% 1989
2022
Q2
$422K Buy
+25,060
New +$386K ﹤0.01% 1788

Other funds holding ACMR

MetLife Investment Management's ACMR Position: Q2 2026 in Review

MetLife Investment Management increased its ACM Research (ACMR) stake by 13% in Q2 2026, buying an estimated $249K and bringing the position to 31,382 shares worth $3.98M. The position accounts for 0.02% of the portfolio, ranked #769.

MetLife Investment Management first reported a position in ACMR in Q2 2022 and has held it in 17 quarters since. 376 funds tracked by Wall St. Rank hold ACMR as of Q2 2026.

  • MetLife Investment Management held 31,382 shares of ACM Research worth $3.98M as of Q2 2026.
  • MetLife Investment Management bought 3,528 ACM Research shares in Q2 2026, an estimated $249K.
  • ACM Research made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #769 holding.
  • MetLife Investment Management first reported a position in ACM Research in Q2 2022 and has held it in 17 quarters since.
  • 376 funds tracked by Wall St. Rank held ACM Research as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.